TY - JOUR
T1 - F-18-labeling syntheses and preclinical evaluation of functionalized nanoliposomes for Alzheimer's disease
AU - Rokka, J
AU - Snellman, A
AU - Kaasalainen, M
AU - Salonen, J
AU - Zona, C
AU - Ferla B, La
AU - Nicotra, F
AU - F, Re
AU - Masserini, M
AU - Forsback, S
AU - Lopez-Picon, F
AU - Rinne, JO
AU - Haaparanta-Solin, M
AU - Solin, Olof
PY - 2016
Y1 - 2016
N2 - Although the studied functionalized F-18-NLs were not suitable for PET imaging as such, the synthesis techniques introduced in this study can be utilized to modify the biological behavior of F-18-labeled NLs. (C) 2016 Elsevier B.V. All rights reserved.
AB - Although the studied functionalized F-18-NLs were not suitable for PET imaging as such, the synthesis techniques introduced in this study can be utilized to modify the biological behavior of F-18-labeled NLs. (C) 2016 Elsevier B.V. All rights reserved.
KW - Alzheimer's disease
KW - beta-amyloid plaques
KW - Functionalized nanoliposomes
KW - Nucleophilic 18F-fluorination
KW - Positron emission tomography (PET)
KW - Alzheimer's disease
KW - beta-amyloid plaques
KW - Functionalized nanoliposomes
KW - Nucleophilic 18F-fluorination
KW - Positron emission tomography (PET)
KW - Alzheimer's disease
KW - beta-amyloid plaques
KW - Functionalized nanoliposomes
KW - Nucleophilic 18F-fluorination
KW - Positron emission tomography (PET)
U2 - 10.1016/j.ejps.2016.03.016
DO - 10.1016/j.ejps.2016.03.016
M3 - Artikel
SN - 0928-0987
VL - 88
SP - 257
EP - 266
JO - European Journal of Pharmaceutical Sciences
JF - European Journal of Pharmaceutical Sciences
ER -